Self-Expanding Hydra Transcatheter Heart Valve (THV) Series Versus Balloon-Expandable Devices for Valve-In-Valve Transcatheter Aortic Valve Implantation (TAVI) for Patients With Failed Surgical Aortic Bioprosthesis.

计划入组 111 人 · 首次发布于 2026 年 4 月 13 日

LANDMARK Trial: a Randomised Controlled Trial of Myval THV

计划入组 988 人 · 首次发布于 2020 年 2 月 19 日

A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System

计划入组 1,650 人 · 首次发布于 2025 年 9 月 26 日

ThV-01

ThV-02

L200 Series

CL GOLD BULLION FUND ETF CAD DOLLAR HEDGED SERIES UNITS

Daan Gene Co.,Ltd.

China

Suzhou Fushilai Pharmaceutical Co.,Ltd.

Meril's Myval Transcatheter Heart Valve Shows Comparable One-Year Outcomes to Leading Competitors in LANDMARK Trial

Meril's Myval THV Series Demonstrates Non-Inferiority in Landmark Head-to-Head TAVI Trial

FDA Approves Edwards' Sapien M3 as First Transseptal Mitral Valve Replacement System